PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape
This educational series is supported by independent educational grants from AstraZeneca and Merck. CME Available: https://auau.auanet.org/node/31198 Based on the documented need from the 2019 AUA gl...
31 Maalis 202151min
Metastatic Hormone Sensitive Prostate Cancer - Expert Guidance For Urologists
This educational series is supported by independent educational grants from: Astellas, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC and Pfizer, Inc. CME Available: https://a...
26 Maalis 202153min
Impacts of COVID-19 on Urology Training and Education
Impacts of COVID-19 on Urology Training and Education by American Urological Association
17 Maalis 202135min
Crossfire In Urology - Robotic Reconstruction
Crossfire In Urology - Robotic Reconstruction by American Urological Association
10 Maalis 202131min
Adjuvant Treatment In Bladder Cancer
At the conclusion of this activity, participants will be able to: 1. Discuss the evolving landscape of adjuvant therapy for the treatment of advanced bladder cancer and analyze the risks and benefits ...
3 Maalis 202138min
AUA Guidelines Case - Based Panel Stress Urinary Incontinence
AUA Guidelines Case - Based Panel Stress Urinary Incontinence by American Urological Association
23 Helmi 202130min
Panel Discussion - Peyronie's Disease Management
Panel Discussion - Peyronie's Disease Management by American Urological Association
19 Helmi 202130min
Pain Management In Urologic Surgery
Pain Management In Urologic Surgery by American Urological Association
11 Helmi 202130min
